Registration number: 09126851

Cheshire Cardiology Limited

Contents

Abridged Balance Sheet	1 to 2
Notes to the Unaudited Abridged Financial Statements	3 to 4

Cheshire Cardiology Limited

(Registration number: 09126851)
Abridged Balance Sheet as at 31 March 2026

	Note	2026 £	2025 £
Fixed assets
Tangible assets	4	610,527	669,491
Current assets
Stocks	5	31,569	72,884
Debtors		112,589	93,479
Cash at bank and in hand		232,980	119,010
		377,138	285,373
Creditors: Amounts falling due within one year	6	(217,403)	(194,750)
Net current assets		159,735	90,623
Total assets less current liabilities		770,262	760,114
Creditors: Amounts falling due after more than one year	7	(324,412)	(377,323)
Provisions for liabilities		(103,646)	(87,477)
Net assets		342,204	295,314
Capital and reserves
Called up share capital		100	100
Profit and loss account		342,104	295,214
Total equity		342,204	295,314

Cheshire Cardiology Limited

(Registration number: 09126851)
Abridged Balance Sheet as at 31 March 2026

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 9 July 2026 and signed on its behalf by:
 

Ms E Dutton

Director

Mr A Hill

Director

Cheshire Cardiology Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The School House
Chester Road
Northwich
Cheshire
CW8 1LE
England

These financial statements were authorised for issue by the Board on 9 July 2026.

2	Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover represents the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Leasehold improvements	15% straight line
Motor vehicles	25% reducing balance

Cheshire Cardiology Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

Plant and machinery

20% reducing balance

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2025 - 12).

4	Tangible assets

	Total £
Cost or valuation
At 1 April 2025	1,089,319
Additions	102,374
At 31 March 2026	1,191,693
Depreciation
At 1 April 2025	419,828
Charge for the year	161,338
At 31 March 2026	581,166
Carrying amount
At 31 March 2026	610,527
At 31 March 2025	669,491

5

Stocks

	2026 £	2025 £
Stock	31,569	72,884

6	Creditors: amounts falling due within one year

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £64,740 (2025 - £59,300).

7	Creditors: amounts falling due after more than one year

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £324,412 (2025 - £377,325).

8	Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £53,000 (2025 - £106,000).